Mera Bharat Mahan-our nation is great. India’s first indigenous vaccine against Covid-19

Bharath Biotech has maintained a rather low profile since its operations in 1996. Low profile but with high productivity, because it has 160 patents to its credit and has introduced vaccines for more than a dozen diseases like Hib , Poliomyelitis, Diphtheria, Tetanus, Pertussis, H1N1, Rabies, Japanese Encephalitis, Hepatitis B, Rotavirus and Typhoid. With this brilliant track record in the biotech domain, it is not surprising that Bharath Biotech today has manufactured  COVAXIN  India’s ‘first’ indigenous COVID-19 vaccine, developed in collaboration with University of Wisconsin, the Indian Council of Medical Research (ICMR), Thomas Jefferson University and the National Institute of Virology (NIV). Drug Controller General of India (DCGI) has given the go ahead to conduct human trials with COVAXIN. Hearty congratulations to Dr.Krishna M.Ella and his wife Suchitra Ella who returned from US two decades back to lead innovation and their fight against mankind’s dreaded diseases globally from Hyderabad. We keep our fingers crossed for a safe outcome of the human trials. Mera Bharath Mahan.

Published by BhaskarChak

Internet Entrepreneur, Faculty of Marketing and Digital Entrepreneurship, Pharmaceutical Marketing Veteran, TEDx Speaker, Serious Amateur in Clicking & Writing

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: